Reports: FDA expected to authorize Pfizer for adolescents by next week

Ivana Saric
·1 min read

The Food and Drug Administration is expected to authorized the use of the Pfizer-BioNTech coronavirus vaccine for 12- to 15-year-olds by next week, The New York Times reports.

Why it matters: Opening up vaccine eligibility to young people and children will be crucial as the U.S. works to achieve herd immunity.

Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for free

The big picture: The FDA approval for teens could come in early next week or even sooner, per AP.

  • The agency is also expected to approve the vaccine for even younger children in the fall.

  • Pfizer has said its vaccine was 100% effective at protecting against COVID-19 in a trial of more than 2,200 children between the ages of 12 and 15.

More from Axios: Sign up to get the latest market trends with Axios Markets. Subscribe for free